ArticleJournal of bioethical inquiry2025
Healthcare Professionals and Unregulated Commercial Surrogacy in China: Ethical and Legal Challenges.
Article in Journal of bioethical inquiry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent reports from 2023 and 2024 have brought to light alarming instances of healthcare professionals in China being involved in commercial surrogacy arrangements. These cases reveal the dual roles these professionals play: active facilitation, which includes actions such as selling fraudulent birth certificates that contribute to baby trafficking, and passive involvement, where routine medical care is provided to surrogate mothers without full awareness of the surrogacy context. Current regulations in China broadly prohibit surrogacy-related medical activities but fail to differentiate between healthcare professionals who actively facilitate surrogacy arrangements and those who fulfil their professional obligations to patients. Drawing on professional ethics outlined in the revised 2021 Medical Practitioners Law of the People's Republic of China and recent developments in modern slavery scholarship that emphasize the critical role of healthcare professionals in identifying and preventing exploitation, this paper argues that China has an opportunity to clarify and broaden the role of healthcare professionals in the context of surrogacy. Healthcare professionals should not be prohibited from providing medical care to surrogate mothers, provided they are not actively facilitating surrogacy arrangements. Simultaneously, they should be empowered to act as gatekeepers against exploitation. This would be an important step toward enhancing the current regulatory framework, ensuring better protections for children and women involved in surrogacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.